Computerized Response Inhibition Training For Children With Trichotillomania by Lee, Han-Joo et al.
Marquette University
e-Publications@Marquette
Psychology Faculty Research and Publications Psychology, Department of
4-1-2018
Computerized Response Inhibition Training For
Children With Trichotillomania
Han-Joo Lee
University of Wisconsin - Milwaukee
Flint M. Espil
Stanford University School of Medicine
Christopher C. Bauer
Marquette University
Stephan G. Siwiec
University of Wisconsin - Milwaukee
Douglas W. Woods
Marquette University, douglas.woods@marquette.edu
Accepted version. Psychiatry Research, Vol. 262 (April 2018): 20-27. DOI. © 2018 Elsevier B.V. Used
with permission.
 Marquette University 
e-Publications@Marquette 
 
Psychology Faculty Research and Publications/College of Arts and Sciences 
 
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The 
published version may be accessed by following the link in the citation below. 
 
Psychiatry Research, Vol. 262, (2018): 20-77. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for 
this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier.  
 
Computerized response inhibition training for 
children with trichotillomania 
 
Han-JooLee 
Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 
Flint M.Espil 
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 
Stanford, CA 
Christopher C.Bauer 
Department of Psychology, Marquette University, Milwaukee, WI 
Stephan G.Siwiec 
Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 
Douglas W.Woods 
Department of Psychology, Marquette University, Milwaukee, WI 
 
Abstract 
Evidence suggests that trichotillomania is characterized by impairment in response inhibition, 
which is the ability to suppress pre-potent/dominant but inappropriate responses. This study 
sought to test the feasibility of computerized response inhibition training for children with 
trichotillomania. Twenty-two children were randomized to the 8-session response inhibition 
training (RIT; n = 12) or a waitlisted control (WLT; n = 10). Primary outcomes were assessed 
by an independent evaluator, using the Clinical Global Impression-Improvement (CGI-I), and 
the NIMH Trichotillomania Severity (NIMH-TSS) and Impairment scales (NIMH-TIS) at pre, 
post-training/waiting, and 1-month follow-up. Relative to the WLT group, the RIT group showed 
a higher response rate (55% vs. 11%) on the CGI-I and a lower level of impairment on the 
NIMH-TIS, at post-training. Overall symptom reductions rates on the NIMH-TSS were 34% 
(RIT) vs. 21% (WLT) at post-training. The RIT's therapeutic gains were maintained at 1-month 
follow-up, as indicated by the CGI-I responder status (= 66%), and a continuing reduction in 
symptom on the NIMH-TSS. This pattern of findings was also replicated by the 6 waitlisted 
children who received the same RIT intervention after post-waiting assessment. Results 
suggest that computerized RIT may be a potentially useful intervention for trichotillomania. 
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1. Introduction 
Trichotillomania (TTM) is characterized by recurrent pulling of one's own hair with unsuccessful 
attempts to stop the behavior, resulting in hair loss, and significant physical and/or 
psychosocial impairment (Duke et al., 2010, Woods et al., 2006a). Despite its impact, TTM 
remains a poorly understood and underdiagnosed disorder for which effective and durable 
treatments are lacking; particularly in children (Duke et al., 2010). 
Repetitive hair-pulling and failure to resist the urges suggests deficient response inhibition (RI) 
in TTM (Bohne et al., 2008, Chamberlain et al., 2006, Chamberlain et al., 2009). RI has 
received much attention as a cognitive deficit underlying TTM. RI enables one to suppress pre-
potent or dominant responses that are no longer appropriate, which also constitutes a key 
component of executive control for flexible and goal-directed behavior (Aron et al., 2004, 
Verbruggen and Logan, 2008). Neuroimaging evidence indicates the right-lateralized inferior 
frontal cortex (rIFC) as a central locus of inhibition (Aron et al., 2004). A recent review has also 
suggested that rIFC and its associated networks function as a “brake” over response 
tendencies (Aron et al., 2014). 
Research suggests a possible link between TTM and RI deficits. First, most behavioral studies 
in adult TTM have shown signs of RI deficiency on the Stroop (Bohne et al., 2005), go/no-go 
(Bohne et al., 2008), and stop/signal-tasks (Chamberlain et al., 2006). Further, a significant 
correlation between RI deficits (i.e., extended stop-signal reaction times) and TTM symptom 
severity was observed (r = 0.56, p < 0.02; Chamberlain et al., 2006). Second, TTM has been 
hypothesized to stem from deficits in cortical-striatal-thalamic-cortical circuits (Mataix-Cols and 
van den Heuvel, 2006) and there are growing neuroimaging data supporting this view. Adults 
with TTM showed structural abnormalities in these regions, which are implicated in RI 
processes (van Velzen et al., 2014): abnormally increased grey matter densities in the left 
striatum, and several cortical regions (including frontal and supplementary motor) bilaterally 
(Chamberlain et al., 2008); excessive cortical thickness in neural regions relevant for RI, 
including the right inferior/middle frontal gyri (Odlaug et al., 2014); reduced basal ganglia 
volumes (O'Sullivan et al., 1997); reduced cerebellar volumes (Keuthen et al., 2007); reduced 
left inferior frontal gyrus volume (Grachev, 1997); and reduced white matter tract connectivity 
in prefrontal striatal circuitry involved in motor habit generation and suppression (Chamberlain 
et al., 2010). In contrast, there is a marked lack of behavioral and neuroimaging research on RI 
in pediatric TTM. Very few behavioral studies exist that have examined children with TTM vs. 
healthy controls on RI or related executive functions. Brennan et al. (2016) found that children 
with TTM performed better than healthy controls on the stop-signal task, although they had 
hypothesized escalated RI deficits in TTM. Another study reported impaired executive 
functioning in reversal learning, planning, and organization among children with TTM as 
compared with healthy controls (Flessner et al., 2016). Thus, there are very limited and mixed 
data regarding the deficits in RI and related cognitive functioning in pediatric TTM. Therefore, 
much research is needed to better understand RI processes in pediatric TTM, as the overall 
literature points to the importance of RI in TTM and its relevance for treatment of the disorder 
(Chamberlain et al., 2006, Chamberlain et al., 2009, van Velzen et al., 2014) with some even 
suggesting impaired RI as a candidate endophenotype of TTM (Odlaug et al., 2014). 
Despite the documented benefits of behavior therapy (McGuire et al., 2014, Ninan et al., 2000, 
Woods et al., 2006a) and clomipramine (McGuire et al., 2014, Swedo et al., 1989), treatment 
literature for TTM is scarce and limited by numerous methodological issues (Woods et al., 
2006a). This is particularly true in pediatric TTM, which is even more troubling considering that 
the estimated age of onset is 13 years and TTM characterized by an earlier age of onset tends 
to display poorer RI (Bohne et al., 2008). To enhance our field's understanding of TTM around 
its time of onset and facilitate treatment development, randomized controlled trial research 
focusing on a relevant treatment target is much needed (Harrison and Franklin, 2012). Despite 
the relevance of RI processes for TTM, no RI-focused cognitive intervention appears to exist 
for TTM. 
We conducted a pilot clinical trial to examine the effect of a computerized cognitive training 
focused on improving RI processes for children with TTM. We predicted that systematic 
training of RI would result in the improvement in symptoms of TTM. Therefore, we 
hypothesized that, relative to the waitlist control, the RI training condition would show greater 
improvement in TTM symptoms and RI processes. 
2. Method 
2.1. Participants 
We recruited children with TTM. A total of 45 children were phone-screened, and 27 
underwent an onsite eligibility assessment. Informed consent was obtained from the parent or 
legal guardian of each participant prior to beginning the onsite eligibility assessment. They 
were informed that this study aimed to test a computerized intervention designed to address 
the difficulty in inhibition of behaviors, which may help individuals with problematic repetitive 
behaviors. Inclusion criteria were (a) ages 9–17 years, and (b) primary diagnosis of TTM 
(DSM-IV criteria). Exclusion criteria included (a) active psychosis, (b) visual impairments 
(interfering with computer tasks), (c) parent-reported developmental disabilities, (d) low overall 
IQ (< 79), (e) unstable medication status (= change within 4 weeks prior to or during study), 
and (f) past/current substance use disorder. Twenty-two children met the study entry criteria 
and were randomized to the RI training (RIT; n = 12) or the waitlisted (WLT; n = 10) condition 
(See Fig. 1), utilizing computerized random numbers. Their average age was 13.18 (SD = 
2.42). They were largely female (77.3%, n = 17) and Caucasian (86.4%, n = 19). Two children 
(1 in RIT, and 1 in WLT) discontinued the intervention (or waiting). Thus, data analysis 
included 20 children who completed the post-intervention/waiting assessment (n = 11 for RIT, 
n = 9 for WLT). 
 
Fig. 1. Flow of study. 
2.2. Measures 
2.2.1. Treatment response status 
The Clinical Global Impression Scale (CGI; Guy, 1976) is a clinician-rated scale for assessing 
the severity of the illness (CGI-S) and clinical improvement (CGI-I) from baseline on a 7-point 
scale. Scores of 1 (very much improved) or 2 (much improved) on the CGI-I were used to 
indicate a positive treatment response. The CGI was administered by a well-trained 
independent evaluator (IE) who was blind to the intervention conditions. The CGI has 
displayed good psychometric properties in child studies (De Los Reyes et al., 2011, Tolin et 
al., 2007), and has also been used as the main categorical outcome measure in existing 
psychosocial randomized controlled trials for pediatric TTM (Franklin et al., 2011, Morris et al., 
2016). 
2.2.2. Hair pulling symptoms 
The National Institute of Mental Health Trichotillomania Questionnaire (NIMH-TQ; Swedo et 
al., 1989) is a clinician-administered scale for rating TTM symptoms, consisting of the Severity 
(NIMH-TSS) and Impairment (NIMH-TIS) scales. The NIMH-TSS assesses various aspects of 
TTM symptoms (i.e., time spent pulling, resistance to urges, overall distress, and interference) 
on a 0–5 scale. The NIMH-TIS offers a global assessment of functional impairment due to 
pulling on a scale from 0 (no impairment) to 10 (severe). The NIMH-TQ has demonstrated 
good psychometric properties in adults with TTM (Diefenbach et al., 2006, Stanley et al., 1999) 
and good test-retest and interrater reliability for children with TTM (Franklin et al., 2011). 
Further, the NIMH-TQ is sensitive to treatment-induced symptom change in adult TTM 
(Rothbaum, 1992, Woods et al., 2006b). It has also served as the primary outcome measure in 
existing psychosocial controlled trials for pediatric TTM (Franklin et al., 2011, Morris et al., 
2016). In this study, a thoroughly trained and experienced master's level clinician served as a 
blinded independent evaluator (IE), and 25% of the recorded ratings were reviewed by an 
independent rater (interrater-rater agreement = 0.91 based on intraclass correlation 
coefficient). 
The Trichotillomania Scale for Children (Tolin et al., 2008) is a widely-used 12-item hair pulling 
symptom scale with both child and parent versions (TSC-C and TSC-P), providing indices of 
Severity and Impairment, and their summed total score. The TSC has shown good 
psychometric properties (McGuire et al., 2012, Tolin et al., 2008). 
2.2.3. Diagnostic measures 
The Trichotillomania Diagnostic Interview (TDI; Rothbaum and Ninan, 1994) is a semi-
structured interview to assess the DSM-IV criteria for Trichotillomania. 
The Anxiety Disorders Interview Schedule (ADIS) for DSM-IV - Child and Parent Versions 
(Silverman and Albano, 2004) is a structured diagnostic interview that assesses major anxiety, 
mood, and externalizing disorders among children and adolescents aged 7–18. Youth and 
parents answer questions on the child and parent versions, respectively. The ADIS has 
demonstrated excellent psychometric properties (Langer et al., 2010, Silverman et al., 2001, 
Wood et al., 2002). 
2.2.4. Overall intellectual functioning 
The Wechsler Abbreviated Scale of Intelligence (WASI) assesses intellectual functioning for 
individuals ages 6–89 years (Wechsler, 1999). The WASI produces a reliable estimate of an 
overall level of intellectual functioning. 
2.2.5. RI assessment tasks 
The Stop Signal Task (SST) was designed following the paradigm established and utilized for 
children (Carter et al., 2003, Lindqvist and Thorell, 2009). During the practice block, 
participants completed 15 go trials, requiring a prompt response to a red triangle on each trial. 
The main block presented 60 trials (2/3 were go-trials; 1/3 were stop trials displaying “Stop” 
following the go signal). The 60% duration of each child's mean RT (which was computed from 
the practice block for each child) was set as the stop-signal delay (i.e., the length of delay 
between the go stimulus and the stop signal), which was suggested as a theoretically 
meaningful interval for this paradigm to evaluate RI (Carter et al., 2003). The total number of 
commission errors (i.e., the erroneous response on the stop trial) served as the main index of 
RI deficits from this task. 
The Go/No-Go task (Aycicegi et al., 2003, Lapierre et al., 1995, Lee et al., 2009) presented 
three, 40-trial blocks. Block 1 asked participants to promptly respond to a blue cross, to form a 
potent go-response tendency. In Block 2, participants were asked to respond promptly to the 
blue cross (2/3 of the trials), while inhibiting response to the blue star (1/3 of the trials). The 
target and distracter were reversed in Block 3 to increase the demand for inhibitory control. 
The total number of commission errors (i.e., erroneous response to the distracter) in Blocks 2 
and 3 served as the RI index on this task. 
2.2.6. Treatment acceptability 
We administered self-reported items selected and adapted from the Treatment Acceptability 
Questionnaire (Hunsley, 1992) to explore the acceptability and tolerability of RIT: (a) 
acceptability, (b) ethicalness, and (c) acceptability of side effects (for both children and 
parents); and (d) pleasantness, and (e) distress (only for children). They were rated on a 7-
point scale (e.g., Overall, how acceptable did you find the treatment to be? 1 = very 
unacceptable ~ 7 = very acceptable; How pleasant do you think this treatment was? 1 = very 
unpleasant ~ 7 = very pleasant). 
2.3. Response inhibition training program (RIT) 
Incorporating parameters of the go/no-go and stop-signal paradigms, RIT is a 30-level 
computer game, designed to provide systematic practice of RI focused on action withholding 
and action cancellation processes (Sebastian et al., 2013). Main task materials are simple 
geometric figures (e.g, blue/red squares and circles), comprising (a) go trial, (b) no-go trial, and 
(c) stop trial. Participants practice withholding response to pre-potent stimulus (no-go trials) 
and cancelling ongoing response (stop trials), while selectively responding to appropriate 
targets. In each session, participants completed three 10-min game levels, each of which 
contained an average of 188 trials, with brief inter-level breaks. After completing each level, a 
result page was presented to summarize the participant's performance. 
All children in RIT and 6 waitlisted children (who crossed over to RIT) completed all 8 sessions 
of training, spending 240 min in total with no variation across children. Training was conducted 
in a small therapy room in our Psychology clinic, using a laptop computer. After a research 
assistant (RA) set up the computer, the child completed the training session following 
instructions included within the training program. While staying at a comfortable distance from 
the participant, the RA remained in the room to assist the participant as needed and ensure 
the participants’ adherence to the training program. However, all children completed the 
training procedures following the embedded instructions with very little assistance from the RA. 
RIT is different from a mere repetition of existing go/no-go or SST in several important ways: 
(a) utilizing ascending levels, RIT becomes more difficult by systematically varying RI task 
parameters (i.e., increasing stop-signal delay latencies [the initial value was set at 200 ms and 
increased by an average of 12 ms at each level], and potentiating no-go trials by switching the 
shape/color of the stimuli); (b) RIT guides participants to make individually-tailored progress 
toward more difficult levels (i.e., each level is repeated until accuracy of 95% is reached); (c) 
RIT contains video-game features to increase participant's motivation (e.g., mastering levels 
and display of session record scores); and (d) RIT provides trial-by-trial performance feedback 
to help participants make conscious efforts to improve their ongoing RI performance. 
2.4. Procedure 
Participants who completed the baseline measures (including questionnaires, clinician-
administered ratings, and RI assessment tasks) were randomized to RIT or WLT. The RIT 
group completed 8 twice-weekly sessions of training over a 4-week period, followed by a post-
training assessment. The WLT group underwent post-waiting assessment after the 4-week 
waiting period. The primary outcome measures (i.e., CGI, NIMH-TSS, and NIMH-TIS) were 
administered by the blinded IE. The RIT group was assessed at 1-month follow-up again for 
the long-term outcome. Aside from the twice-weekly sessions, there were no between-session 
assignments or any further training during the follow-up period. For ethical considerations, 
following the post-waiting assessment, the WLT group was discontinued from the study and 
was offered the RIT intervention (i.e., cross-over training over 4 weeks). Completers were 
assessed to examine the outcomes of the cross-over training. 
3. Results 
3.1. Demographic and clinical characteristics at baseline 
At pre-training, the RIT and WLT groups showed no significant differences on age, gender, 
race, overall intellectual functioning, the percentage of those with comorbid diagnoses (RIT = 
27% [n = 3] vs. WLT = 44% [n = 4]), or the percentage of those receiving other treatments (RIT 
= 18% [n = 2] vs. WLT = 33% [n = 3]. No group difference was found on the severity of TTM 
symptoms (the NIMH-TSS, TSC-P, and TSC-C) or the global severity of illness (the CGI-S). 
Overall, the two groups were equivalent (see Table 1). 
Table 1. Baseline demographic and clinical characteristics. 
 RIT (n = 11) WLT (n = 9)   
 Mean SD Mean SD t (χ2) p 
Age 12.91 2.39 13.11 2.52 0.18 0.86 
Gender (% Male) 27% (n = 3) 22% (n = 2) (χ2 = 0.07) 0.80 
Race White 100% (n = 11) 67% (n = 6) (χ2 = 4.31) 0.12 
 Asian 0% (n = 0) 22% (n = 2)   
 African American 0% (n = 0) 11% (n = 1)   
Pulling Site       
 Scalp 64% (n = 7) 78% (n = 7)   
 Eyelashes 45% (n = 5) 44% (n = 4)   
 Eyebrows 45% (n = 5) 11% (n = 1)   
 Face 18% (n = 2) 11% (n = 1)   
 Pubic 9% (n = 1) 11% (n = 1)   
 Arms/Legs 18% (n = 2) 22% (n = 2)   
NIMH-TSS 10.45 2.51 11.11 2.57 0.58 0.57 
NIMH-TIS 5.09 1.04 4.56 1.13 1.10 0.29 
TSC-Parent Severity 1.31 0.55 1.29 0.33 0.10 0.93 
TSC-Parent Impairment 0.87 0.56 1.04 0.58 0.67 0.51 
TSC-Parent Total 2.18 1.00 2.33 0.76 0.37 0.71 
TSC-Child Severity 1.18 0.48 1.22 0.37 0.21 0.84 
TSC-Child Impairment 0.92 0.41 0.95 0.36 0.15 0.88 
TSC-Child Total 1.96 0.76 2.06 0.78 0.29 0.77 
CGI-Severity 4.36 0.50 4.33 0.50 0.13 0.90 
WASI 112.18 10.40 111.33 12.51 0.17 0.87 
Comorbidity Status       
 Any comorbid diagnoses 27% (n = 3) 44% (n = 4) (χ2 = 0.64) 0.42 
 Major depressive disorder 9% (n = 1) 22% (n = 2)   
 Generalized anxiety disorder 9% (n = 1) 11% (n = 1)   
 Social anxiety disorder 9% (n = 1) 11% (n = 1)   
 ADHD 9% (n = 1) 11% (n = 1)   
Current Treatmenta 18% (n = 2) 33% (n = 3) (χ2 = 0.61) 0.44 
 RIT (n = 11) WLT (n = 9)   
 Mean SD Mean SD t (χ2) p 
 Counseling/talk therapy 9% (n = 1) 11% (n = 1)   
 Pharmacotherapy 18% (n = 2) 22% (n = 2)   
 Stimulants 9% (n = 1) 11% (n = 1)   
 Antidepressants 18% (n = 2) 22% (n = 2)   
Note. NIMH-TSS = the National Institute of Mental Health Trichotillomania Questionnaire 
Severity Scale; NIMH-TIS = the National Institute of Mental Health Trichotillomania 
Questionnaire Impairment Scale; TSC-Parent = the Trichotillomania Scale for Children - Parent 
Version; TSC-Child = the Trichotillomania Scale for Children - Child Version; CGI = the Clinical 
Global Impression Scale; WASI = the Wechsler Abbreviated Scale of Intelligence. 
aCounseling was a general talk therapy for depression/anxiety symptoms for both children. There was 
no significant change in the treatment status in all participants throughout the study. 
3.2. Response status on the CGI-I after training/waiting 
Participants who were rated as 1 or 2 on the CGI-I at post-training were categorized as 
responders. The percentage of responders was 55% in the RIT group (very much improved [n 
= 4]), much improved [n = 2]), vs. 11% in the WLT group (very much improved [n = 1]). In a N-
1 Chi-square test (Pearson, 1947), which is a sensitive and reliable test for a 2 × 2 contingency 
table with cells of low expected values (i.e., less than 5; Campbell, 2007), the response rate 
was significantly higher in the RIT, relative to the WLT group: N-1 χ2= 3.90, p = 0.048. 
3.3. Hair pulling on the NIMH-TSS and NIMH-TIS at post-training 
In an ANCOVA, the RIT group showed a numerically lower total score on the NIMH-TSS than 
the WLT group at post-training after controlling for the baseline severity, but the difference was 
not statistically significant: RIT - Mean = 6.91 (SD = 4.37) vs. WLT - Mean = 8.78 (SD = 2.86), 
F(1,17) = .84, p = 0.373, η2 = .03 (small to medium effect size). Overall symptom reduction 
rates were 34% and 21% from the baseline level, for the RIT and WLT groups, respectively. 
The RIT group (mean = 2.50 [= minimal impairment], SD = 2.22) showed a significantly lower 
level of impairment on the NIMH-TIS than the WLT group (mean = 3.56 [= minimal to mild 
impairment], SD = 1.74) after controlling for the baseline level: F(1,17) = 4.87, p = 0.041, η2 
= .14 (large effect size).1 
3.4. Long-term outcomes at 1-month follow-up 
Long-term outcomes were examined only for the RIT group as the WLT group did not take 
follow-up measures. On the CGI-I, the response status of the RIT group remained favorable at 
1-month follow-up. Of the 6 responders at post-training, 5 completed the follow-up assessment 
and all of them maintained the responder status. Of the 5 non-responders at post-training, 4 
completed the follow-up assessment and 2 of them became responders (very much improved 
[n = 1], much improved [n = 1]). Thus, aside from one responder who was lost during the 
follow-up period, 7 out of 9 RIT follow-up completers (78%) were responders at follow-up (very 
much improved [n = 3], and much improved [n = 4]). 
A similar pattern was observed on the NIMH –TSS. Among the 9 RIT study completers, 
compared to their baseline severity (mean = 10.89, SD = 2.57), symptom reduction rates were 
33% at post-assessment (mean = 7.33, SD = 4.66) and 56% at follow-up (mean = 4.78, SD = 
3.53). When considering all RIT participants, paired t-tests showed that their NIMH-TSS scores 
were significantly lower at post-training than at baseline, t(10) = 3.36, p = 0.007, d = 0.91 (large 
effect); and lower at follow-up than at post-training, t(8) = 2.89, p = 0.020, d = 0.57 (medium 
effect). These findings suggest continued symptom reduction during the follow-up period 
despite the discontinuation of the training. 
3.5. Outcomes of the crossover RIT training 
Of the 9 WLT participants, 6 received RIT after the post-waiting assessment. Prior to crossing 
over to RIT, all were deemed non-responders, but 4 of them (= 66%) became responders after 
the cross-over training (very much improved [n = 1], much improved [n = 3] on the CGI-I). For 
these 6 participants, the rate of symptom reduction from the baseline was 16.1% at post-
waiting assessment. However, after the cross-over training, their pulling severity was further 
reduced by 52% from the baseline level on the NIMH TSS, which is comparable to the 
symptom reduction rate of the RIT group. The NIMH-TSS total score was significantly lower 
after cross-over RIT training (mean = 5.00, SD = 2.83), relative to the severity at post-waiting 
(mean = 8.67, SD = 3.20; t (5) = 3.12, p = 0.026, d = 1.21 [large effect]). 
3.6. Self- and parent-reported symptom scores 
Paired t-tests were conducted to examine changes in symptoms on the TSC-C and TSC-P 
(Table 2). In the RIT group, scores on the TSC-C Impairment, TSC-P Severity, TSC-P 
Impairment, and TSC-P Total were significantly lower at post-training than at baseline. These 
differences remained significant at 1-month follow-up. In the WLT group, a significant reduction 
at post-waiting was observed only on the TSC-C Impairment and TSC-C Total. Additionally, 
ANCOVAs were conducted to compare these scores at post-training/waiting while controlling 
for baseline levels. Relative to the WLT group, the RIT group showed a marginally significant 
trend of lower scores on the TSC-P Severity, F(1, 17) = 3.70, p = 0.071, η2 = .09, and TSC-P 
Total, F(1, 17) = 4.29, p = 0.055, η2 = .08. However, there were no group differences on the 
TSC-C Severity, F(1,17) = 0.68, p = .42, η2 = .03, TSC-C Impairment, F(1,17)=.003, p = 0.957, 
η2 = .00, TSC-C Total, F(1,17) = .41, p = 0.53, η2 = .01, or TSC-P Impairment, F(1, 16) = 1.40, 
p = 0.253, η2 = .04, at post-training. 
Table 2. Scores on the TSC-C and TSC-P and paired t-tests on their change from baseline level. 
 RIT WLT 
 Pre Post FU Pre Post Crossover 
TSC-C Severity Mean 1.18 1.07 0.89 1.22 0.93 0.76 
 RIT WLT 
 Pre Post FU Pre Post Crossover 
 (SD) (0.37) (0.52) (0.49) (0.37) (0.45) (0.52) 
Pre vs. Post t(10) = 0.79, p = 0.449 t(8) = 1.84, p = 0.103 
Pre vs. FUa t(8) = 1.84, p = 0.103  
TSC-C Impairment Mean 0.92 0.66 0.59 0.95 0.66 0.85 
 (SD) (0.41) (0.46) (0.49) (0.36) (0.36) (0.56) 
Pre vs. Post t(10) = 4.35**, p = 0.002 t(8) = 2.47*, p = 0.039 
Pre vs. FU t(8) = 4.95**, p = 0.001  
TSC-C Total Mean 1.96 1.58 1.34 2.06 1.48 1.41 
 (SD) (0.76) (0.86) (0.78) (0.78) (0.79) (1.06) 
Pre vs. Post t(10) = 2.25, p = 0.051 t(8) = 2.41*, p = 0.043 
Pre vs. FU t(8) = 3.57**, p = 0.007  
TSC-P Severity Mean 1.31 0.96 1.09 1.29 1.28 0.97 
 (SD) (0.55) (0.63) (0.48) (0.33) (0.45) (0.67) 
Pre vs. Post t(10) = 2.38*, p = 0.039 t(8) = 0.12, p = 0.911 
Pre vs. FU t(8) = 2.89*, p = 0.020  
TSC-P Impairment Mean 0.87 0.50 0.54 1.04 0.81 0.60 
 (SD) (0.56) (0.43) (0.41) (0.58) (0.57) (0.16) 
Pre vs. Post t(10) = 2.61*, p = 0.028 t(8) = 2.28, p = 0.052 
Pre vs. FU t(8) = 3.35*, p = 0.010  
TSC-P Total Mean 2.18 1.44 1.63 2.33 2.09 1.57 
 (SD) (1.00) (0.85) (0.72) (0.76) (0.92) (0.76) 
Pre vs. Post t(10) = 3.47**, p = 0.007 t(8) = 1.83, p = 0.104 
Pre vs. FU t(8) = 3.67**, p = 0.006  
Note. Pre = pre-training assessment; Post = post-training/waiting assessment; FU = 1-month 
follow-up assessment; Crossover = post-crossover training assessment; TSC-Parent = the 
Trichotillomania Scale for Children - Parent Version; TSC-Child = the Trichotillomania Scale for 
Children - Child Version. 
aPre vs. FU – These paired-t-tests compared the baseline vs. 1-month FU scores for the RIT group. 
This analysis was not conducted on the WLT group due to the absence of the follow-up assessment in 
this condition. 
*p < 0.05. 
**p < 0.01. 
3.7. Changes in RI measures 
3.7.1. SST 
At baseline, there were no group differences on the indices of the SST: RT on Block 1, t(18) 
= .21, p = 0.84, RT on Block 2, t(18) = .1.15, p = 0.27, and overall commission errors, t(18) 
= .49, p = 0.63. In an ANCOVA controlling for commission errors at pre-training and the current 
RT, the RIT group made significantly fewer commission errors than the WLT group at post-
training, F(1,16) = 7.39, p = 0.015, η2 = .30 (large effect). Within the RIT group, commission 
errors were significantly lower at post-training than at baseline, t(10) = 2.29, p = 0.045, but the 
number of commission errors at follow-up were not significantly lower compared to baseline, 
t(8) =1.04, p = 0.328, or post-training level, t(8) = 1.13, p = 0.290. 
3.7.2. Go/No-Go task 
There were no significant group differences on the number of commission errors, t(16) = 1.28, 
p = 0.22, or overall RT, t(16) = 1.41, p = 0.20 at baseline, or at post-training while controlling 
for baseline levels, F(1,15) = .28, p = 0.60. Within the RIT group there were no significant 
reductions in commissions errors at post-training, t(10) = 1.30, p = 0.22, or at 1-month follow-
up, t(8) = .86, p = 0.42 (see Table 3). 
Table 3. Means and standard deviations of the RI measures. 
 RIT WLT 
 Pre Post FU Pre Post Crossover 
Stop-Signal Task       
 Reaction Time Mean 577.68 647.75 638.82 661.04 671.78 608.19 
 (SD) (156.11) (157.34) (166.47) (180.41) (242.71) (175.91) 
 Commission Errors Mean 5.91 2.73 4.11 4.89 5.11 4.40 
 (SD) (4.53) (3.26) (4.51) (4.83) (5.23) (5.86) 
Go/No-Go Task       
 Reaction Time Mean 448.41 436.50 444.83 503.93 503.04 459.43 
 (SD) (46.76) (87.57) (74.10) (97.74) (98.94) (126.15) 
 Commission errors Mean 5.91 4.64 5.00 3.71 3.00 3.50 
 (SD) (3.91) (2.98) (4.82) (2.87) (2.31) (2.38) 
Note. Pre = pre-training assessment; Post = post-training/waiting assessment; FU = 1-month 
follow-up assessment; Crossover = post-crossover training assessment. 
3.8. Correlations between reductions in commissions errors and in pulling symptoms 
We examined how pre-to post changes in RI indices were associated with pre-to post or pre-to 
follow-up changes in symptoms, utilizing their residual change scores (Table 4). The change 
on the NIMH-TSS was not significantly correlated with changes in commission errors on both 
RI tasks. However, the pre-to post reduction on the NIMH-TIS showed moderate-sized 
correlations (= .30 ~ .36) with the reduction in commission errors on both RI tasks. On the 
TSC-C and TSC-P, pre-to post and pre-to follow-up reductions on their Impairment subscales 
showed moderate to large correlations (= .35 − .77) with reductions in commission errors on 
both RI tasks. These findings offer some preliminary evidence that the reductions in 
commission errors after the RI training can be positively associated with improvement on some 
indices of hair pulling symptoms, especially the level of impairment associated with hair pulling. 
Table 4. Zero-order correlations (p values) between reductions in commission errors and 
reductions in symptom severity in the RIT group. 
  Reduction in Commission Errors 
  Stop Signal Task Go/No-Go Task 
Pre-Post Sx Change NIMH Total 0.19 (0.59) 0.25 (0.46) 
 NIMH Global 0.30 (0.37) 0.36 (0.29) 
 TSC-C Severity −0.22 (0.52) 0.00 (0.99) 
 TSC-C Impairment 0.49 (0.15) 0.77 (0.01)* 
 TSC-P Severity 0.13 (0.70) 0.34 (0.30) 
 TSC-P Impairment 0.35 (0.32) 0.42 (0.23) 
Pre-FU Sx Change NIMH Total −0.02 (0.96) 0.1 (0.80) 
 NIMH Global 0.19 (0.63) −0.03 (0.93) 
 TSC-C Severity −0.19 (0.62) −0.05 (0.89) 
 TSC-C Impairment 0.53 (0.14) 0.51 (0.16) 
 TSC-P Severity −0.23(0.55) 0.07 (0.85) 
 TSC-P Impairment 0.56 (0.12) 0.74 (0.02)* 
Note. All reductions scores in this table are standardized residual change scores computed by 
regressing post-training scores onto their baseline scores. 
*p < 0.05. 
3.9. RIT acceptability and tolerability 
Results showed that the RIT was overall well accepted and tolerated: (a) acceptability (Mean = 
5.77, SD=1.42 for parents; Mean = 6.21, SD = 1.31 for children), (b) ethicalness (Mean = 6.62, 
SD = 0.96 for parents; Mean = 6.36, SD = 1.15 for children), and (c) acceptability of side 
effects (Mean = 6.73, SD = 0.90 for parents; Mean = 5.79, SD = 2.04 for children). Children 
also reported the RIT as overall pleasant (mean = 5.86, SD = 1.70) and non-distressing (mean 
= 5.79, SD = 1.12). 
4. Discussion 
Aiming to test the feasibility of RI training as a therapeutic intervention for youths with TTM, we 
observed encouraging preliminary data. At post-training, relative to WLT, RIT produced a 
significantly higher response rate (55% vs. 11%) and a significantly lower level of pulling-
related impairment on the NIMH-TIS. Although the group difference on the NIMH-TSS did not 
reach statistical significance, the symptom reduction rate was also in the favor of RIT vs. WLT 
(34% vs. 21%). Relative to WLT, RIT also showed a marginally significant trend for lower 
parent-rated pulling severity (TSC-P). Further, acute training gains of RIT remained at 1-month 
follow-up. Aside from one RIT responder who was lost to follow-up, 7 out of 9 RIT completers 
(78%) were responders at follow-up. Notably, two out of 5 RIT non-responders at post-training 
achieved responder status at follow-up. Among these 9 RIT completers, the pulling severity 
(NIMH-TSS) continued to decrease during the follow-up period: symptom reductions rates 
were 33% at post-assessment and 56% at follow-up. These findings were replicated among 6 
WLT children who completed the cross-over RIT. Although all of them were non-responders at 
post-waiting, 4 (= 66%) became responders after training, and their pulling severity decreased 
to 52% of the baseline level, similar to the therapeutic gains observed in the RIT group. 
In the only randomized controlled trial of behavior therapy (BT) for children with TTM to date, 
Franklin and colleagues (2011) reported promising results of an 8-week BT protocol combined 
with an 8-week maintenance treatment (against a minimum attention control condition). At 
week 16, for the BT condition, the mean NIMH-TSS score was 2.5 (SD = 3.4) and 75% of the 
participants were responders on the CGI-I. Our 9 RIT study completers achieved overall 
comparable therapeutic gains at the end of the study: the mean NIMH-TSS = 4.8 (SD = 3.5) 
and response rate = 78% (7 out of 9 were responders) at follow-up. These findings are 
encouraging considering the brief, computerized, and portable format of the RIT. To date, 
moderate to large effect sizes have been reported from existing BT trials for adults and mixed 
samples (ages 16 and up) of TTM (Azrin et al., 1980, Diefenbach et al., 2006, Ninan et al., 
2000, van Minnen et al., 2003, Woods et al., 2006a). Importantly, among the trials including 
follow-up assessments, several note a partial return of symptoms (Azrin et al., 1980, Franklin 
et al., 2011, Keuthen et al., 2012, Woods et al., 2006b) or eventual relapse (Diefenbach et al., 
2006) over periods up to 22 months. Although this study only conducted a 1-month follow-up 
assessment, treatment response was maintained for the majority of participants, with some 
even displaying further improvement. 
Consistent with our hypothesis, RIT showed significantly lower commission errors relative to 
WLT on the SST at post-training, which offers preliminary support for the RI-enhancing 
function of RIT. However, our findings on RI were overall mixed and should be interpreted with 
caution. Among RIT trainees, despite their reduction in TTM symptoms, the reduction in SST 
commission errors at post-training was attenuated at follow-up (i.e., not significantly different 
from the pre-training level any more), and a negligible reduction was observed in go/no-go 
commission errors. What are possible reasons for the discrepancy between the two RI tasks 
and the overall modest RI findings? Several issues need to be considered. First, although the 
RIT program includes both go/no-go and SST parameters (i.e., no-go trials and stop signals), 
the impact of its training might differ across the distinguishable RI components that are known 
to have both shared and specific neural subprocesses (Sebastian et al., 2013). Future 
research needs to examine systematically whether a certain RI component (e.g., action 
cancelation assessed primarily by SST) is more amenable to change via RIT than others (e.g., 
action withholding assessed primarily by go/no-go). 
Second, it is possible that behavioral RI may not reveal the full spectrum of changes in 
underlying RI processes, as compensatory responses at neural levels could emerge to 
obscure behavioral expressions of RI. Researchers suggest that the failure to find behavioral 
evidence of RI deficits can be due to compensatory brain activation during inhibition (van 
Velzen et al., 2014). Thus, modest changes in behavioral RI performance do not exclude the 
possibility of improved RI processes at neural levels. Future research should assess RI at 
neurocognitive levels including an fMRI assessment of RI-related neural circuit activity to 
obtain a fuller picture of changes in RI. 
Third, it is possible that children with TTM may display only a limited facet of RI deficits, and 
cognitive deficits associated with TTM in adults may not emerge until later in the development 
(Brennan et al., 2016). Evidence also suggests that the main structure of executive functioning 
(including inhibition, shifting, and updating; see Miyake et al., 2000) remains undifferentiated in 
early childhood and become more specific and dissociable with age (Xu et al., 2013). Overall, 
the developmental neuroscience literature indicates that the inhibitory control function emerges 
rapidly during the first few years of life, followed by slow but continuing improvement through 
adolescence and early adulthood, with more localized, lateralized, and efficient brain activation 
in specific prefrontal cortex regions (e.g., left ventral PFC) relevant for inhibition (for a review, 
Best and Miller, 2010). Taken together, even well-established RI measures could suffer the 
problem of “task impurity” especially when applied to young individuals, due to the malleability 
of RI and its possible interaction with other related executive functions (e.g., working memory) 
over the course of development (Best and Miller, 2010, Xu et al., 2013), which might result in 
markedly variable (and thus less reliable) estimates of inhibition processes among children 
(Brennan et al., 2016). Thus, this line of research (a) critically needs more developmental 
sensitive measures of RI and (b) should assess RI while systematically considering its 
developmental trajectory using a much larger pediatric sample. 
Fourth, the current potency of the RIT might have been insufficient to yield sufficiently large, 
enduring effects on behavioral RI performance. Future studies should attempt to establish (a) a 
criterion-level of RI change that is associated with clinically meaningful symptom change, and 
(b) the optimal dosage of RIT that can produce enduring, criterion-level change in RI. 
Fifth, it is also possible that TTM symptom reductions have been promoted by other 
unassessed but TTM-relevant cognitive functions such as attention (e.g., Lee et al., 2012) 
improved by RIT. Overall, reduction in commissions errors on both the SST and go/no-go 
tasks were moderate- to largely correlated with reductions in hair pulling on the TSC scales, 
especially reductions in pulling-related impairment at follow-up, although the association was 
not pronounced with TTM severity. This is also aligned with the possibility that RIT may 
improve other RI-related cognitive processes, which may lead to overall improved functioning, 
beyond just those specific to pulling symptoms. Existing evidence also shows that pediatric 
TTM is characterized by impairments in other related executive functioning, including planning, 
organization, and reversal learning (Flessner et al., 2016). This study was underpowered to 
conduct a formal mediational test to examine the mechanism of change in RIT, and was not 
able to assess other relevant cognitive processes due to the limited scope of the study. Thus, 
future research should conduct a formal mediation test with an adequate sample to elucidate 
the mechanism of change in RIT, including other measures of RI-related executive functioning 
and cognitive processes to establish the specificity of RI-focused intervention, and its possible 
transfer effects on untrained but adjacent functions. 
Lastly, given the modest change in RI, we cannot exclude the possibility that the observed 
TTM reduction was merely reflecting RI-irrelevant non-specific factors such as expectation or 
attention from the staff. For the current pilot study, a waitlist was an appropriate control group 
in establishing the feasibility of the RIT, but future studies should include a more adequate 
comparison group to establish the specificity of RI-focused cognitive training while controlling 
for non-specific factors. 
A few additional limitations and future directions of the study should be noted. First, we cannot 
exclude the influence of other unintended factors on the RIT outcomes at follow-up (e.g., 
spontaneous recovery or repeated assessment), as the WLT control group crossed over to RIT 
without a comparable follow-up assessment. Second, despite the promising results, this is a 
pilot feasibility study with a small clinical sample comprising of predominantly Caucasian 
females. Consequently, the current study was not adequately powered to detect modest 
intervention effects of RIT on some important outcome variables such as TTM symptom 
severity as assessed by the NIMH-TSS. Take together, replications with larger, more 
representative clinical samples are critically needed to more adequately evaluate the size of 
RIT effects and their statistical and clinical significance, as well as its underlying mechanism of 
action. 
In sum, the current pilot study demonstrated the feasibility of the RIT as a potentially effective 
intervention for children with TTM. Considering the developmental trajectory of RI and its 
malleability during childhood/adolescence, the effort to develop an intervention specifically 
focused on this cognitive deficit for young individuals with TTM seems theoretically and 
clinically important. If successful, this line of work can also lead to the development of a cost-
effective, time-efficient, and portable form of clinical intervention for TTM in particular, and 
perhaps for other numerous conditions sharing RI deficits as an underlying cognitive deficit. A 
successfully developed RIT may also be easily disseminated using various technology 
platforms and utilized as a stand-alone treatment or as an adjunctive intervention for existing 
treatments. Future research for RIT seems warranted to demonstrate its efficacy in a larger 
clinical scale and examine its specific mechanism of action. 
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